Send to

Choose Destination
See comment in PubMed Commons below
J Am Acad Dermatol. 1998 Sep;39(3):464-75.

Cyclosporine consensus conference: with emphasis on the treatment of psoriasis.

Author information

Department of Dermatology at the Mount Sinai School of Medicine, New York, New York 10029-6574, USA.


Cyclosporine has been in worldwide use for 15 years for patients who have undergone transplantation operations and is now being used to control inflammatory reactions in other organs (eg, joints, bowel, and skin). Neoral, a more consistently absorbed form of cyclosporine, has recently been approved by the Food and Drug Administration for the treatment of psoriasis. This report outlines the indications, contraindications, dosage recommendations, monitoring requirements, adverse events, drug interactions, interactions with other psoriasis treatments, and suggestions for cyclosporine's use in rotational therapy.

Comment in

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center